Organogenesis Holdings Inc.
ORGO
$1.79
$0.031.71%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -922.43% | 117.12% | 4,201.05% | 113.62% | 50.25% |
| Total Depreciation and Amortization | 6.10% | 11.26% | 9.22% | 8.29% | 9.63% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 150.71% | -3.84% | 46.97% | -23.81% | -26.69% |
| Change in Net Operating Assets | 106.38% | 15.87% | -170.78% | -113.33% | -184.89% |
| Cash from Operations | 196.37% | 593.42% | -172.56% | -379.38% | -251.32% |
| Capital Expenditure | 15.62% | -19.54% | -41.06% | -28.66% | 1.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 15.62% | -19.54% | -41.06% | -28.66% | 1.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 83.37% | 83.81% | 98.27% | -833.54% | -889.57% |
| Issuance of Common Stock | -87.92% | -87.92% | -87.42% | 554.84% | 503.87% |
| Repurchase of Common Stock | 88.49% | 88.51% | 92.93% | -2,223.59% | -2,221.45% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -261.10% | -226.00% | -162.81% | 370.87% | 492.42% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -60.62% | -187.01% | -231.46% | -683.64% | -1,827.76% |